Bio Developments

Pic:getty/panoramaimages

Roche to launch high-volume SARS-CoV-2 antigen test

By Rachel Arthur

Roche plans to launch its high-volume Elecsys SARS-CoV-2 Antigen test at the end of 2020 in markets accepting the CE mark; while the company will file for Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA).

Follow us

Products

View more

Webinars